In 2023, there were 147 biopharmaceutical active ingredients for oncology in phase I of the development pipeline in Germany. By contrast, there were only eight for respiratory diseases.
Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2023, by disease group
Phase I/IIa is included in Phase I; Active ingredients included in the approval process in Phase II; Active ingredients in studies conducted worldwide by companies operating in Germany.
¹ Produced biotechnologically and genetically.
² Including antianemics, antithrimbotics, fibrinolytics etc., excluding hematological oncology.
³ Eye and ear diseases.
⁴ Including active ingredients for muscles, bones, cardiovascular system diseases etc.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
vfa. (July 6, 2024). Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2023, by disease group [Graph]. In Statista. Retrieved November 22, 2024, from https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa. "Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2023, by disease group." Chart. July 6, 2024. Statista. Accessed November 22, 2024. https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa. (2024). Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2023, by disease group. Statista. Statista Inc.. Accessed: November 22, 2024. https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa. "Number of Biopharmaceutical Active Ingredients in The Development Pipeline in Germany in 2023, by Disease Group." Statista, Statista Inc., 6 Jul 2024, https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/
vfa, Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2023, by disease group Statista, https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/ (last visited November 22, 2024)
Number of biopharmaceutical active ingredients in the development pipeline in Germany in 2023, by disease group [Graph], vfa, July 6, 2024. [Online]. Available: https://www.statista.com/statistics/1450442/biopharmaceuticals-development-pipeline-germany/
